Bellevue Asset Management
Latest statistics and disclosures from Bellevue Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Celgene Corporation, BIIB, GILD, AMGN, REGN, and represent 17.64% of Bellevue Asset Management's stock portfolio.
- Added to shares of these 10 stocks: IONS (+$8.5M), CAH (+$8.2M), CNC (+$5.6M), Mylan, EGBN, Lannett Company, CVS, BIIB, Radius Health, BAX.
- Started 9 new stock positions in EGBN, Lannett Company, Radius Health, RARE, Biotime Inc wts oct 1 18, Zeltiq Aesthetics, Wright Medical Group Nv, IONS, PTCT.
- Reduced shares in these 10 stocks: Allergan (-$14M), RDY (-$8.3M), Kite Pharma (-$6.5M), ISIS Pharmaceuticals (-$5.3M), ABT, THC, Akorn, Zafgen, Express Scripts Holding, DENTSPLY International.
- Sold out of its positions in Akorn, BioTime, DENTSPLY International, RDY, Dyax, Endologix, Ikang Healthcare Group-, ISIS Pharmaceuticals, PEN, Proshares Tr ultpro nasbio. Theravance, Wright Medical, Zafgen, Allergan, Rewalk Robotics.
- Bellevue Asset Management was a net buyer of stock by $474k.
- Bellevue Asset Management has $656M in assets under management (AUM), dropping by 7.05%.
- Central Index Key (CIK): 0001642343
Portfolio Holdings for Bellevue Asset Management
Bellevue Asset Management holds 127 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Celgene Corporation | 4.0 | $26M | -5% | 217k | 119.76 |
|
| Biogen Idec (BIIB) | 3.9 | $26M | +17% | 84k | 306.35 |
|
| Gilead Sciences (GILD) | 3.7 | $24M | -5% | 240k | 101.19 |
|
| Amgen (AMGN) | 3.0 | $20M | +2% | 123k | 162.33 |
|
| Regeneron Pharmaceuticals (REGN) | 3.0 | $20M | -6% | 36k | 542.86 |
|
| Medtronic | 3.0 | $20M | -5% | 257k | 76.92 |
|
| Illumina (ILMN) | 2.7 | $18M | +4% | 91k | 191.95 |
|
| Abbott Laboratories (ABT) | 2.6 | $17M | -17% | 382k | 44.91 |
|
| Mylan | 2.6 | $17M | +40% | 315k | 54.07 |
|
| Becton, Dickinson and (BDX) | 2.5 | $16M | +13% | 105k | 154.09 |
|
| Cardinal Health (CAH) | 2.3 | $15M | +114% | 172k | 89.27 |
|
| UnitedHealth (UNH) | 2.1 | $14M | 120k | 117.64 |
|
|
| Stryker Corporation (SYK) | 2.0 | $13M | 141k | 92.94 |
|
|
| Teva Pharmaceutical Industries (TEVA) | 1.8 | $12M | +4% | 177k | 65.64 |
|
| Express Scripts Holding | 1.6 | $11M | -22% | 124k | 87.41 |
|
| Endo International (ENDPQ) | 1.6 | $11M | +8% | 171k | 61.22 |
|
| Auris Med Hldg | 1.6 | $10M | 2.2M | 4.80 |
|
|
| Zimmer Holdings (ZBH) | 1.5 | $9.8M | 96k | 102.59 |
|
|
| Alexion Pharmaceuticals | 1.4 | $9.4M | 49k | 190.75 |
|
|
| CVS Caremark Corporation (CVS) | 1.4 | $9.4M | +74% | 96k | 97.77 |
|
| Ligand Pharmaceuticals In (LGND) | 1.4 | $8.9M | -14% | 82k | 108.41 |
|
| Incyte Corporation (INCY) | 1.3 | $8.6M | +2% | 79k | 108.46 |
|
| Ionis Pharmaceuticals (IONS) | 1.3 | $8.5M | NEW | 138k | 61.93 |
|
| Boston Scientific Corporation (BSX) | 1.3 | $8.5M | +15% | 460k | 18.44 |
|
| McKesson Corporation (MCK) | 1.3 | $8.5M | +4% | 43k | 197.23 |
|
| Jazz Pharmaceuticals (JAZZ) | 1.3 | $8.4M | +7% | 60k | 140.57 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $8.4M | -18% | 67k | 125.84 |
|
| St. Jude Medical | 1.1 | $7.5M | 122k | 61.77 |
|
|
| CIGNA Corporation | 1.1 | $7.0M | -17% | 48k | 146.33 |
|
| Centene Corporation (CNC) | 1.1 | $7.0M | +428% | 106k | 65.81 |
|
| BioMarin Pharmaceutical (BMRN) | 1.0 | $6.8M | 65k | 104.75 |
|
|
| AmerisourceBergen (COR) | 1.0 | $6.6M | +6% | 64k | 103.70 |
|
| Insys Therapeutics | 1.0 | $6.6M | +10% | 232k | 28.63 |
|
| Perrigo Company (PRGO) | 1.0 | $6.4M | +10% | 44k | 144.70 |
|
| Intuitive Surgical (ISRG) | 1.0 | $6.3M | -14% | 12k | 546.15 |
|
| Shire | 1.0 | $6.3M | 31k | 205.00 |
|
|
| Coherus Biosciences (CHRS) | 0.9 | $5.9M | +11% | 257k | 22.96 |
|
| Aetna | 0.9 | $5.7M | 53k | 108.11 |
|
|
| Halozyme Therapeutics (HALO) | 0.8 | $5.5M | +29% | 318k | 17.33 |
|
| Edwards Lifesciences (EW) | 0.8 | $5.5M | +55% | 69k | 78.99 |
|
| Humana (HUM) | 0.8 | $5.4M | 30k | 178.50 |
|
|
| Horizon Pharma | 0.8 | $5.3M | +11% | 245k | 21.67 |
|
| Alkermes (ALKS) | 0.8 | $5.2M | +11% | 66k | 79.37 |
|
| Johnson & Johnson (JNJ) | 0.8 | $5.1M | 50k | 102.72 |
|
|
| C.R. Bard | 0.8 | $5.1M | +10% | 27k | 189.44 |
|
| Mallinckrodt Pub | 0.8 | $5.1M | -15% | 68k | 74.63 |
|
| Intersect Ent | 0.8 | $5.1M | +12% | 225k | 22.50 |
|
| Eagle Ban (EGBN) | 0.7 | $4.9M | NEW | 55k | 88.67 |
|
| Supernus Pharmaceuticals (SUPN) | 0.7 | $4.8M | +10% | 355k | 13.44 |
|
| Community Health Systems (CYH) | 0.7 | $4.6M | +7% | 174k | 26.53 |
|
| Achillion Pharmaceuticals | 0.7 | $4.5M | 420k | 10.79 |
|
|
| Lannett Company | 0.7 | $4.3M | NEW | 108k | 40.12 |
|
| Baxter International (BAX) | 0.6 | $4.2M | +120% | 110k | 38.15 |
|
| Anthem (ELV) | 0.6 | $4.2M | 30k | 139.43 |
|
|
| Bristol Myers Squibb (BMY) | 0.6 | $4.1M | 60k | 68.78 |
|
|
| Hca Holdings (HCA) | 0.6 | $4.1M | +50% | 60k | 67.63 |
|
| Neurocrine Biosciences (NBIX) | 0.6 | $3.7M | 65k | 56.57 |
|
|
| Cerner Corporation | 0.6 | $3.6M | +9% | 60k | 60.17 |
|
| Nektar Therapeutics (NKTR) | 0.6 | $3.6M | -10% | 216k | 16.85 |
|
| Pfizer (PFE) | 0.5 | $3.6M | +29% | 110k | 32.28 |
|
| Agios Pharmaceuticals (AGIO) | 0.5 | $3.5M | 54k | 64.93 |
|
|
| Novadaq Technologies | 0.5 | $3.2M | 250k | 12.74 |
|
|
| Hologic (HOLX) | 0.5 | $3.1M | 81k | 38.69 |
|
|
| Merck & Co (MRK) | 0.5 | $3.2M | 60k | 52.82 |
|
|
| Seattle Genetics | 0.5 | $3.1M | +41% | 68k | 44.88 |
|
| Masimo Corporation (MASI) | 0.5 | $3.1M | 75k | 41.51 |
|
|
| Ariad Pharmaceuticals | 0.5 | $3.1M | 495k | 6.25 |
|
|
| Varian Medical Systems | 0.5 | $3.0M | 37k | 80.81 |
|
|
| Medivation | 0.5 | $3.0M | +19% | 63k | 48.33 |
|
| Eli Lilly & Co. (LLY) | 0.5 | $2.9M | 35k | 84.26 |
|
|
| Thermo Fisher Scientific (TMO) | 0.4 | $2.8M | 20k | 141.85 |
|
|
| Novavax | 0.4 | $2.7M | 325k | 8.39 |
|
|
| Qiagen | 0.4 | $2.5M | +14% | 92k | 27.65 |
|
| Macrogenics (MGNX) | 0.4 | $2.6M | 83k | 30.98 |
|
|
| Cooper Companies | 0.4 | $2.5M | 19k | 134.22 |
|
|
| Celldex Therapeutics | 0.4 | $2.5M | 160k | 15.68 |
|
|
| Radius Health | 0.4 | $2.5M | NEW | 40k | 61.55 |
|
| Teleflex Incorporated (TFX) | 0.4 | $2.4M | 19k | 131.43 |
|
|
| NuVasive | 0.4 | $2.4M | 45k | 54.11 |
|
|
| Globus Med Inc cl a (GMED) | 0.4 | $2.4M | 88k | 27.82 |
|
|
| Healthcare Services (HCSG) | 0.3 | $2.3M | 65k | 34.88 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $2.3M | -25% | 24k | 94.12 |
|
| Zeltiq Aesthetics | 0.3 | $2.1M | NEW | 75k | 28.53 |
|
| Prothena (PRTA) | 0.3 | $2.1M | +106% | 31k | 68.10 |
|
| Intercept Pharmaceuticals In | 0.3 | $2.0M | +55% | 14k | 149.33 |
|
| Stericycle (SRCL) | 0.3 | $1.8M | -25% | 15k | 120.60 |
|
| Clovis Oncology | 0.3 | $1.8M | -4% | 53k | 35.01 |
|
| Bluebird Bio (BLUE) | 0.3 | $1.9M | +41% | 29k | 64.21 |
|
| Ptc Therapeutics I (PTCT) | 0.3 | $1.8M | NEW | 55k | 32.40 |
|
| Inovio Pharmaceuticals | 0.3 | $1.8M | 265k | 6.72 |
|
|
| Wright Medical Group Nv | 0.3 | $1.7M | NEW | 70k | 24.18 |
|
| Juno Therapeutics | 0.2 | $1.6M | +12% | 37k | 43.97 |
|
| WellCare Health Plans | 0.2 | $1.6M | 20k | 78.20 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $1.6M | -23% | 45k | 35.64 |
|
| United Therapeutics Corporation (UTHR) | 0.2 | $1.5M | 9.3k | 156.56 |
|
|
| DaVita (DVA) | 0.2 | $1.4M | 20k | 69.70 |
|
|
| Laboratory Corp. of America Holdings (LH) | 0.2 | $1.2M | 10k | 123.60 |
|
|
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $1.3M | +23% | 160k | 7.85 |
|
| AngioDynamics (ANGO) | 0.2 | $1.2M | 100k | 12.14 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $1.1M | NEW | 10k | 112.20 |
|
| Alder Biopharmaceuticals | 0.2 | $1.1M | -23% | 33k | 33.03 |
|
| Exelixis (EXEL) | 0.1 | $959k | +13% | 170k | 5.64 |
|
| Abbvie (ABBV) | 0.1 | $889k | -44% | 15k | 59.27 |
|
| Esperion Therapeutics (ESPR) | 0.1 | $890k | 40k | 22.25 |
|
|
| iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $846k | 2.5k | 338.40 |
|
|
| Kite Pharma | 0.1 | $863k | -88% | 14k | 61.64 |
|
| ResMed (RMD) | 0.1 | $805k | 15k | 53.67 |
|
|
| Affymetrix | 0.1 | $807k | 80k | 10.09 |
|
|
| Impax Laboratories | 0.1 | $770k | 18k | 42.78 |
|
|
| Insulet Corporation (PODD) | 0.1 | $794k | -6% | 21k | 37.81 |
|
| Team Health Holdings | 0.1 | $658k | 15k | 43.87 |
|
|
| Myriad Genetics (MYGN) | 0.1 | $604k | -57% | 14k | 43.14 |
|
| Juniper Pharmaceuticals Incorporated | 0.1 | $515k | 50k | 10.30 |
|
|
| Arbutus Biopharma (ABUS) | 0.1 | $556k | 125k | 4.45 |
|
|
| MannKind Corporation | 0.1 | $435k | 300k | 1.45 |
|
|
| Cardiovascular Systems | 0.1 | $454k | 30k | 15.13 |
|
|
| ImmunoGen | 0.1 | $407k | 30k | 13.57 |
|
|
| Endocyte | 0.1 | $401k | -36% | 100k | 4.01 |
|
| XOMA CORP Common equity shares | 0.1 | $299k | 225k | 1.33 |
|
|
| Tenet Healthcare Corporation (THC) | 0.1 | $303k | -92% | 10k | 30.30 |
|
| HeartWare International | 0.0 | $252k | -88% | 5.0k | 50.40 |
|
| Geron Corporation (GERN) | 0.0 | $218k | 45k | 4.84 |
|
|
| Tetraphase Pharmaceuticals | 0.0 | $221k | 22k | 10.05 |
|
|
| Theravance Biopharma (TBPH) | 0.0 | $187k | 11k | 16.36 |
|
|
| Celladon | 0.0 | $74k | 50k | 1.48 |
|
|
| Asterias Biotherapeutics | 0.0 | $7.0k | 1.9k | 3.73 |
|
|
| Biotime Inc wts oct 1 18 | 0.0 | $3.0k | NEW | 2.3k | 1.31 |
|
Past Filings by Bellevue Asset Management
SEC 13F filings are viewable for Bellevue Asset Management going back to 2015
- Bellevue Asset Management 2015 Q4 filed Feb. 12, 2016
- Bellevue Asset Management 2015 Q3 filed Nov. 12, 2015
- Bellevue Asset Management 2015 Q2 filed Aug. 12, 2015
- Bellevue Asset Management 2015 Q1 filed May 14, 2015